Medical technology breakthroughs have led to a radical transformation in patient care by enabling a greater focus on clinical outcomes. Minimally invasive or non-invasive medical technologies, for instance, not only shorten recovery time but also low ....see more
The global medical device outsourced manufacturing market in terms of revenue was estimated to be worth $29.3 billion in 2021 and is poised to reach $56.2 billion by 2026, growing at a CAGR of 13.9% from 2021 to 2026. The prominent players in this market are Flex, Ltd. (Singapore), Jabil, Inc. (US), TE Connectivity, Ltd. (Switzerland), Sanmina Corporation (US), Nipro Corporation (Japan), Celestica International (Canada), Plexus Corporation (US), Benchmark Electronics, Inc. (US), Integer Holdings Corporation (US), Gerresheimer Ag (Germany), West Pharmaceutical Services, Inc. (US), Nortech Systems, Inc. (US), Consort Medical PLC (UK), Kimball Electronics Inc. (US), and Teleflex Incorporated (US), Nordson Corporation (US), Tecomet, Inc. (US), SMC Ltd. (US), Nemera (France), and Tessy Plastics Corporation (US), among others.
The global Immuno Oncology Assays Market boasts a total value of $4.4 billion in 2021 and is projected to register a growth rate of 12.5% to reach a value of $7.9 billion by 2026. The major players operating in this market are Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (US), Illumina, Inc. (US), NanoString Technologies, Inc. (US), Sartorius AG (Germany), HTG Molecular Diagnostics, Inc. (US), QIAGEN N.V. (Netherlands), Merck Millipore (US), PerkinElmer, Inc. (US), Abbott Laboratories, Inc. (US), Guardant Health, Inc. (US), bioMérieux SA (France), Myriad Genetics, Inc. (US), MESO SCALE DIAGNOSTICS, LLC. (US), Seegene Inc. (South Korea), Bio-Rad Laboratories, Inc. (US), Charles River Laboratories, Inc. (US), Olink (Sweden), ASURAGEN, INC. (US), Invivoscribe, Inc. (US), Creative Biolabs (US), ReachBio LLC (US), and NMI Technologietransfer GmbH (Germany).
The laparoscopic instruments market is expected to grow from USD 12.3 billion in 2021 to USD 22.1 billion by 2026, at a compound annual growth rate (CAGR) of 12.5%. during the forecast period.Intuitive Surgical, Inc. (US), Stryker Corporation (US), Olympus Corporation (Japan), Karl Storz GmbH & CO. KG (Germany), Medtronic PLC (Ireland), Microline Surgical, Inc. (US), B. Braun Melsungen AG (Germany), SCHÖLLY Fiberoptic GmbH (Germany), Optomic (Spain), Victor Medical Instruments Co., Ltd (China), Peters Surgical (France), EndoMed Systems GmbH (Germany), Becton, Dickinson and Company (US), Mindray Medical International Limited (China), CONMED Corporation (US), Richard Wolf GmbH (Germany), Smith & Nephew PLC (UK), Cook Medical (US), Ethicon (US), Strauss Surgical (US), AMNOTEC International Medical (Germany).
The Sterilization Container Systems Market is expected to grow from USD 324 million in 2021 to USD 375 million by 2026, at a CAGR of 3.0% during the forecast period. The global sterilization container systems market is fragmented. The prominent players operating in this market include B. Braun Melsungen AG (Germany), Johnson & Johnson (US), Becton, Dickinson and Company (BD) (US), Integra LifeSciences Corporation (US), Medline Industries, Inc. (US), KLS Martin Group (US), Ritter GmbH (Germany), MELAG Medizintechnik GmbH & Co. KG (Germany), Hu-Friedy Mfg. Co., LLC (US), Case Medical (US), Summit Medical LLC. (US), GPC Medical Ltd. (India), AYGÜN Co., Inc. (Turkey), C.B.M. S.r.l. Medical Equipment (Italy), GPC Medical Ltd. (India), and EMED (Poland).
The global companion animal pharmaceuticals market is expected to grow from USD 12.8 billion in 2021 to USD 18.5 billion by 2026, at a compound annual growth rate (CAGR) of 7.6% during the forecast period.Zoetis Inc. (US), Merck & Co., Inc. (US), Boehringer Ingelheim GmbH (Germany), Elanco Animal Health Incorporated (US), Ceva Santé Animale (France), Virbac (France), Vetoquinol S.A. (France), Dechra Pharmaceuticals plc (UK), Chanelle Pharma (Ireland), Kyoritsu Seiyaku (Japan), Zydus Animal Health and Investments Limited (India), Tianjin Ringpu Bio-Technology Co., Ltd. (China), HIPRA (Spain), Norbrook Holdings Limited (UK), Inovet (Belgium), Endovac Animal Health (US), ECO Animal Health Group plc (UK), Indian Immunologicals Ltd. (India), ALS Pvt. Ltd. (India), and Lutim Pharma Pvt. Ltd. (India).
The global Fertility Test Market in terms of revenue was estimated to be worth $472 million in 2020 and is poised to reach $680 million by 2025, growing at a CAGR of 7.5% from 2020 to 2025. Key players operating in this market are Swiss Precision Diagnostics (Switzerland), Church & Dwight (US), Prestige Brands Holdings (US), bioZhena (US), Fairhaven Health (US), Fertility Focus (UK), Geratherm Medical (Germany), Hilin Life Products (US), UEBE Medical (Germany), AdvaCare Pharma (US), AVA (Switzerland), Babystart (UK), Valley Electronics (Germany), Sensiia (UK), and Mira Care (US),
The global surgical sutures market size is projected to reach USD 4.9 billion by 2026, growing at a CAGR of 6.0%. Prominent players in this market are Ethicon, Inc. (US), Medtronic plc (Ireland), B. Braun Melsungen AG (Germany), Smith & Nephew plc (UK), Boston Scientific Corporation (US), Peters Surgical (France), DemeTECH Corporation (US), Internacional Farmacéutica (Mexico), Sutures India (India), EndoEvolution, LLC (US), Apollo Endosurgery, Inc. (US), Surgical Specialties Corporation (US), and Mellon Medical B.V. (Netherlands).
The global Veterinary Antimicrobial Susceptibility Testing Market in terms of revenue was estimated to be worth $100 million in 2021 and is poised to reach $135 million by 2026, growing at a CAGR of 6.1% from 2021 to 2026. Some of the major players operating in the market are Thermo Fisher Scientific Inc. (US), Becton, Dickinson and Company (US), Bruker Corporation (US), bioMérieux SA (France), Danaher Corporation (US), Bio-Rad Laboratories, Inc. (US), Neogen Corporation (US), HiMedia Laboratories (India), Mast Group Ltd. (UK), Bioguard Corporation (Taiwan), SSI Diagnostica A/S (Denmark), Condalab (Spain), FASTinov SA (Portugal), Synbiosis (UK), Hardy Diagnostics (US), and Liofilchem Srl (Italy).
The global breath analyzer market size is projected to reach USD 1,167 million by 2025, at a CAGR of 17.4%. The prominent players in this market includes Drägerwerk AG & Co. KGaA (Germany), MPD, Inc (US), Lifeloc Technologies (US), BACtrack, Inc. (US), Quest Products, Inc. (US), Akers Biosciences, Inc. (US), Intoximeter, Inc. (US), AK GlobalTech Corporation (US), Alcohol Countermeasure Systems Corporation (Canada), EnviteC-Wismar GmbH (Germany), Lion Laboratories Ltd. (UK)
The global optical imaging market in terms of revenue was estimated to be worth $1.6 billion in 2021 and is poised to reach $3.3 billion by 2026, growing at a CAGR of 14.8% from 2021 to 2026. The market is dominated by a few globally established players such as Abbott Laboratories (US), Carl Zeiss Meditec AG (Germany), Canon (Japan), Topcon Corporation (Japan) and Koninklijke Philips (Netherlands)
The global newborn screening market size is projected to reach USD 1.3 billion by 2026, at a CAGR of 8.3% during the forecast period. Prominent players of this market are PerkinElmer (US), Demant A/S (Denmark), Natus Medical (US), Bio-Rad Laboratories (US), Danaher Corporation (US), and Medtronic (Ireland). Others include Chromsystems Instruments & Chemicals GmbH (Germany), Trivitron Healthcare (India), Baebies (US), Parseq Lab (Russia), and Recipe Chemicals+Instruments (Germany).
The global urology devices market in terms of revenue was estimated to be worth $38.0 billion in 2021 and is poised to reach $46.4 billion by 2026, growing at a CAGR of 4.1% from 2021 to 2026. The major players operating in this market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International Inc. (US), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), Olympus Corporation (Japan), B. Braun Melsungen AG (Germany), Stryker Corporation (US), KARL STORZ (Germany), Cook Medical (US), Intuitive Surgical (US), Medtronic plc (Ireland), Cardinal Health (US), Teleflex Incorporated (US), Richard Wolf GmbH (Germany), CompactCath (US), Dornier MedTech (Germany), Nikkiso Co., Ltd. (Japan), Balton Sp. z o.o. (Poland), Dialife SA (Switzerland), Maxer Endoscopy GmbH (Germany), Vimex Sp. z o.o. (Poland), Amsino International, Inc. (US), ROCAMED (Monaco), Well Lead Medical Co., Ltd. (China), Medispec (US), Medical Technologies of Georgia (Georgia), EndoMed Systems GmbH (Germany), Hunter Urology (England), J and M Urinary Catheters LLC (US), and Ribbel International Limited (India).
The global Intraoperative Imaging Market in terms of revenue was estimated to be worth $1.9 billion in 2020 and is poised to reach $2.5 billion by 2025, growing at a CAGR of 5.2% from 2020 to 2025. Prominent players in this market are Canon Healthcare (Japan), Stryker (US), Brainlab AG (Germany), IMRIS (US), Shimadzu Corporation (Japan), Shenzhen Anke High-tech Co. (China), Hitachi, Ltd. (Japan), FUJIFILM Holdings (Japan), Carl Zeiss Meditec AG (Germany), Mindray Ltd. (US), Carestream Health (US), Analogic Corporation (US), Allengers Medical Systems Ltd. (India), Esaote SpA (Italy) and NeuroLogica Corporation (US).
The nuclear imaging equipment market is expected to reach USD 3.4 billion by 2025, at a CAGR of 4.9% during the forecast period. Siemens Healthineers (Germany), Philips Healthcare (Netherlands), and GE Healthcare (US), are some of the leading players of the nuclear imaging equipment market.
The Global Benign Prostatic Hyperplasia Treatment Market is expected to grow from USD 10.8 billion in 2021 to USD 14.1 billion by 2026, at a compound annual growth rate (CAGR) of 5.3% during the forecast period.Boston Scientific Corporation (US), Coloplast Group (Denmark), Teleflex Incorporated (US), Olympus Corporation (Japan), GlaxoSmithKline PLC (UK), Eli Lilly (US), Pfizer, Inc. (US), Abbott (US), Asahi Kasei Corporation (Japan), Merck & Co., Inc. (US), Astellas Pharma Inc. (Japan), Allergan plc (Ireland), Alembic (India), IPG Photonics Corporation (US), Richard Wolf GmbH (Germany), Unilab, Inc. (Philippines), Pharex Health Corporation (Philippines), Biolitec AG (Austria), Urologix, LLC (US), Advin Health Care (India), Medifocus, Inc. (Canada), Asclepion Laser Technologies GmbH (Germany), Pnn Medical A/S (Denmark), Surgical Lasers Inc. (Canada). Quanta Systems (Italy), Allium Ltd. (Israel), Lumenis Ltd. (Israel), KARL STORZ SE & Co. KG (Germany), and SRS Medical (US).
The global intraoperative radiation therapy market is projected to reach USD 66 million by 2025 from USD 48 million in 2020, at a CAGR of 6.4% during the forecast period. The major players operating in the intraoperative radiation therapy market are ZEISS Group (Germany), iCAD, Inc. (US), Eckert & Ziegler (Germany), Elekta AB (Sweden), GMV Innovating Solutions (Spain), Sensus Healthcare, Inc. (US), IntraOp Medical, Inc. (US), Isoray, Inc. (US), Becton, Dickinson and Company (US), Sordina IORT Technologies (Italy), Varian Medical Systems, Inc. (US), SeeDos Ltd. (UK), IsoAid LLC (US), Ariane Medical Systems Ltd. (UK), Panacea Medical Technologies Pvt. Ltd. (India), Salutaris Medical Devices (US), Brainlab AG (Germany), RaySearch Laboratories (Sweden), REMEDI Co., Ltd. (South Korea), Merit Medical Systems, Inc. (US), among others.
The Surgical Imaging Market is expected to grow from USD 1.8 billion in 2020 to USD 2.4 billion by 2025, at a CAGR of 6.3% during the forecast period. Some of the prominent players operating in the surgical imaging market include vendors GE Healthcare (UK), Siemens AG (Germany), Koninklijke Philips (Netherlands), and Ziehm Imaging (Germany)
The global artificial cornea and corneal implant market in terms of revenue was estimated to be worth $418 million in 2021 and is poised to reach $599 million by 2026, growing at a CAGR of 7.4% from 2021 to 2026. Some of the major players operating in the market are AJL Ophthalmic (Spain), CorneaGen Inc. (US), Addition Technology, Inc. (US), LinkoCare Life Sciences AB (Sweden), Presbia plc (Ireland), Mediphacos (Brazil), Aurolab (India), Cornea Biosciences (US), DIOPTEX GmbH (Austria), EyeYon Medical (Israel), Massachusetts Eye and Ear (US), Florida Lions Eye Bank (US), SightLife (US), Advancing Sight Network (US), San Diego Eye Bank (US) and L V Prasad Eye Institute (LVPEI, India).
The Dental Impression Systems Market is expected to grow from USD 1.3 billion in 2020 to USD 1.9 billion by 2025, at a CAGR of 7.7% during the forecast period. 3M (US), Henry Schein (US), Dentsply Sirona (US), Mitsui Chemicals (Japan), and Envista (US) are the key players operating in the dental impression systems market. Other prominent players in this market include Parkell, Inc. (US), Kettenbach GmbH & Co. KG (Germany), Zest Dental Solutions (US), Keystone Industries (US), Ultradent Products, Inc. (US), Septodont Holding (US), GC Corporation (US), DETAX (Germany), Kerr Corporation (US), Ivoclar Vivadent (US), Kuraray Co. Ltd. (Japan), BEGO (Germany), Premier Dental Products Company (US), and DMG America (US).
The global Womens Health Diagnostics Market boasts a total value of $25.0 billion in 2020 and is projected to register a growth rate of 7.9% to reach a value of $36.6 billion by 2025. The prominent players in this market are Quest Diagnostics Incorporated (US), Hologic, Inc. (US), Abbott Laboratories (US), Siemens AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health, Inc. (US), General Electric Company (US), and Becton, Dickinson and Company (US).
The global Clinical Chemistry Analyzers Market boasts a total value of $12.3 billion in 2021 and is projected to register a growth rate of 4.3% to reach a value of $15.2 billion by 2026. Some of the key players are F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Abbott Laboratories (US), Thermo Fisher Scientific Inc. (US), Siemens AG (Germany), HORIBA Ltd. (Japan), Sysmex Corporation (Japan), HITACHI (Japan), EKF Diagnostics (UK), Ortho Clinical Diagnostics (US), ELITech Group (France), Mindray Medical International Ltd. (China), BIOBASE Group (China), SFRI Medical Diagnostics (France), Trivitron Healthcare Pvt. Ltd. (India), Randox Laboratories Ltd. (UK), Medica Corporation (US), Meril Life Sciences Pvt. Ltd. (India), Erba Mannheim (UK), Genrui Biotech Inc. (China), DIRUI Industrial Co. Ltd. (China), Teco Diagnostics (US), Balio Diagnostics (France), Snibe Co. Ltd. (China), and AMS Alliance (Italy).
The global blood culture tests market size is projected to reach USD 6.1 billion by 2025, at a CAGR of 8.9%. Major players operating in this market includes Becton, Dickinson and Company (US), Thermo Fisher Scientific, Inc. (US), bioMérieux SA (France), Luminex Corporation (US), Danaher Corporation (US), Bruker Corporation (US), IRIDICA (US), Roche Diagnostics (Switzerland), T2 Biosystems, Inc. (US), Anaerobe Systems, Inc. (US), OpGen, Inc. (US), Meditech Technologies India Private Limited (India), Carl Zeiss AG (Germany), Nikon Corporation (Japan), BINDER GmbH (Germany), Biobase Biotech (Jinan) Co., Ltd. (China), Scenker Biological Technology Co., Ltd. (China), Bulldog Bio, Inc. (US), Axiom Laboratories (India), and HiMedia Laboratories Pvt. Ltd. (India).
The Fluid Management Systems Market is projected to reach USD 16.1 Billion by 2025 at a CAGR of 13.6% during the forecast period. The prominent players in this market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International Inc. (US), Cardinal Health, Inc. (US), Stryker Corporation (US), Olympus Corporation (Japan), B. Braun Melsungen AG (Germany), Medline Industries, Inc. (US), KARL STORZ GmbH & Co. KG (Germany), Ecolab Inc. (US), Smiths Medical (UK), Zimmer Biomet Holdings Inc. (US), Medtronic plc (Ireland), FUJIFILM Holdings Corporation (Japan), CONMED Corporation (US), Hologic, Inc. (US), Arthrex, Inc. (US), Thermedx, LLC. (US), COMEG Medical Technologies (Germany), and EndoMed Systems GmbH (Germany).
The global protein A resin market boasts a total value of $1.1 billion in 2020 and is projected to register a growth rate of 11.4% to reach a value of $1.9 billion by 2025. Some of the major players operating in the market are GE Healthcare (US), Merck Millipore (Germany), Repligen Corporation (US), Thermo Fisher Scientific (US), Tosoh Bioscience (Japan), Purolite Corporation (US), Novasep Holding SAS (France), Agilent Technologies (US), GenScript Biotech Corporation (China), PerkinElmer (US), Bio-Rad Laboratories (US), Orochem (US), Kaneka Corporation (Japan), Abcam (UK), Agarose Bead Technologies (US), Avantor (US), JSR Life Sciences (US), Bio-Works Technologies (Sweden), Amikozen Co. Ltd. (US), and Takara Bio Inc. (Japan).
The global interventional cardiology devices market in terms of revenue was estimated to be worth $17.5 billion in 2022 and is poised to reach $25.5 billion by 2027, growing at a CAGR of 7.7% from 2022 to 2027. Prominent players in the market are Medtronic (US), Boston Scientific Corporation (US), Abbott (US), Cardinal Health (US), iVascular (Spain), Edward Lifescinces Corporation (US), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Biosensors International Group (Singapore), and BIOTRONIK SE & Co. KG (Germany).
The global albumin & creatinine tests market size is projected to reach USD 2,103 million by 2025, at a CAGR of 16.3% during the forecast period. The major players operating in this market are Thermo Fisher Scientific, Inc. (US), Roche Diagnostics (Switzerland), PromoCell GmbH (Germany), Abbott Laboratories (US), Siemens Healthineers (Germany), Danaher Corporation (US), Sysmex Corporation (Japan), Ortho Clinical Diagnostics (US), Randox Laboratories (UK), FUJIFILM Wako Pure Chemical Corporation (Japan), Abbexa Ltd. (UK), ACON Laboratories, Inc. (US), Arbor Assays Inc. (US), ARKRAY Global Business Inc. (Japan), Aviva Systems Biology (US), Axxora, LLC (UK), BioAssay Systems (US), Nova Biomedical (US), Quantimetrix Corporation (US), RayBiotech Inc. (US), Sekisui Diagnostics PEI Inc. (US), Teco Diagnostics (US), Tulip Diagnostics (India), ulti med Products GmbH (Germany), and URIT Medical Electronic Co., Ltd. (China).
The global Foot and Ankle Devices Market boasts a total value of $3.9 billion in 2020 and is projected to register a growth rate of 6.4% to reach a value of $5.3 billion by 2025. DePuy Synthes Companies (US), Stryker Corporation (US), Zimmer Biomet Holdings, Inc (US), Smith & Nephew plc (UK), Arthrex Inc (US), Integra LifeSciences Holdings Corporation (US), DJO Finance, LLC (US), CONMED Corporation (US), Össur HF (Iceland), Orthofix Medical Inc. (US), Medartis AG (Switzerland), Acumed LLC (US), Extremity Medical (US), aap Implantate AG (Germany), Ottobock SE & Co. KGaA (Germany), Ortho Solutions UK Ltd. (UK), Vilex in Tennessee, Inc. (US), Advanced Orthopaedic Solutions (US), Fillauer LLC (US), and Groupe FH Ortho (France),among others are some of the major players operating in the global foot and ankle devices market.
The Fluoroscopy Equipment Market is expected to grow from USD 5.9 billion in 2020 to USD 7.5 billion by 2025, at a CAGR of 4.8% during the forecast period. Major players operating in the fluoroscopy equipment market include Siemens Healthineers (Germany), GE Healthcare (US), Philips (Netherlands), Shimadzu Corporation (Japan), Ziehm Imaging (Germany), Canon Medical Systems (Japan), Hitachi (Japan), Carestream Health (US), Hologic (US), Lepu Medical Technology (China), Agfa-Gevaert Group (Belgium), and ADANI Systems (Belarus).
The autoinjectors market is projected to reach USD 104.9 billion by 2025 CAGR of 17.9%. The prominent players in this market are AbbVie Inc. (US), Mylan (US), Eli Lilly and Company (US), Ypsomed (Switzerland), Amgen (US), Becton, Dickinson and Company (US), GlaxoSmithKline plc (UK), Johnson & Johnson (US), Teva Pharmaceutical (Israel), Antares Pharma (US), Merck KGaA (Germany).
The medical robots market is projected to reach USD 12.7 billion by 2025, at a CAGR of 16.5%. Some of the prominent players operating in the medical robots market include Intuitive Surgical (US), Stryker Corporation (US), Accuray (US), Omnicell, Inc.(US), BD Rowa (US), Hocoma AG (Switzerland), Medtronic (Ireland), Smith & Nephew (UK), ARxIUM (Canada),
The Antimicrobial Susceptibility Testing Market is expected to grow from USD 3.2 billion in 2020 to USD 4.2 billion by 2025, at a CAGR of 5.5% during the forecast period. bioMérieux SA (France), Becton, Dickinson and Company (US), Thermo Fisher Scientific (US), Danaher Corporation (US), Bio-Rad Laboratories, Inc. (US), Bruker (US), Roche Diagnostics Limited (Switzerland), Accelerate Diagnostics, Inc. (US), Merck KGaA (US), Hi-Media Laboratories (India), Liofilchem S.r.l. (Italy), Alifax S.r.l. (Italy), Creative Diagnostics (US), Synbiosis (UK), Bioanalyse (Turkey), ZHUHAI DL BIOTECH Co., Ltd. (China), ELITechGroup (France), Mast Group Ltd. (UK), CONDALAB (Spain), Genefluidics, Inc. (US), Biotron Ltd (Australia), InvivoGen (US), MP Biomedicals (US), QuantaMatrix Inc. (South Korea), and PML Microbiologicals Inc. (US), among others are some of the major players operating in the global AST market.
The Clinical Microbiology Market is projected to reach USD 5.3 billion by 2025, at a CAGR of 6.5%. Prominent players in this market include bioMérieux (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), Roche Diagnostics (Switzerland), Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), 3M (US), Bio-Rad Laboratories (US), Bruker Corporation (US), and Hologic (US).
The contact lenses market size is projected to reach USD 10.2 billion by 2025, growing at a CAGR of 6.7%. Some of the prominent players in this market are Johnson & Johnson (US), Alcon (Switzerland), The Cooper Companies (US), Bausch + Lomb (US), Carl Zeiss Meditec AG (Germany), HOYA Corporation (Japan), EssilorLuxottica (France), SEED Co., Ltd. (Japan), Menicon Co., Ltd. (Japan), and BenQ Materials Corporation (Taiwan).
The Adhesion Barrier Market is projected to reach USD 769 million by 2025, at a CAGR of 7.8% during the forecast period. The adhesion barriers market is a highly fragmented market with the presence of several multinational and local market players. Some of the prominent players include Baxter International (US), Johnson & Johnson (J&J) (US), Becton, Dickinson and Company (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), MAST Biosurgery (Switzerland), Innocoll (Ireland), Betatech Medical (Turkey), CorMatrix Cardiovascular, Inc. (US), Terumo Corporation (Japan), BiosCompass (US), W.L.Gore & Associates (US), and Allosource (US).
The global breast biopsy market is projected to reach USD 1,094 million by 2025, at a CAGR of 8.6%. The major players operating in this market are Hologic, Inc. (US), Becton, Dickinson and Company (US), Danaher Corporation (US), Merit Medical Systems (US), QIAGEN (Netherlands), Biocept Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Menarini Silicon Biosystems, Spa (Italy), Exact Sciences Corporation (US), Illumina, Inc. (US), and Fluxion Biosciences Inc (US), among others.
The Prefilled Syringes Market is projected to reach USD 8.6 billion by 2025, at a CAGR of 9.0% during the forecast period. Becton, Dickinson and Company (US), Gerresheimer (Germany), SCHOTT AG (Germany), and West Pharmaceutical Services, Inc. (US) are the key players in the global prefilled syringes market.
The US therapeutic plasma exchange market is projected to reach USD 243 million by 2025, at a CAGR of 6.3%. The prominent players in the US therapeutic plasma exchange market are Terumo BCT, Inc. (US), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Asahi Kasei Medical Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Cerus Corporation (US), Kaneka Corporation (Japan), Kawasumi Laboratories, Inc. (Japan), Nikkiso Co., Ltd. (Japan), Miltenyi Biotec (Germany), Medica S.p.A. (Italy), Medicap Clinic GmbH (Germany), and Infomed (Switzerland).
The cardiac monitoring devices market is projected to reach USD 26.8 billion by 2025, at a CAGR of 4.0%. The major players operating in this market are Medtronic (Ireland), Boston Scientific (US), Abbott Laboratories (US), GE Healthcare (US), BIOTRONIK (Germany), and Koninklijke Philips (Netherlands), Asahi Kasei Corporation (Japan), MicroPort Scientific Corporation (China), Hill-Rom Holdings (US), Nihon Kohden (Japan), SCHILLER AG (Switzerland), BioTelemetry (US), BPL Medical Technologies (India), ACS Diagnostics (US), Shenzhen Mindray Bio-Medical Electronics (China), Lepu Medical Technology (China), Shree Pacetronix (India), OSYPKA (Germany), and BTL t(US), Alivecor, Inc. (US), Amiitalia (Italy), Bexen Cardio (Spain), Narang Medical Limited (India), MeTrax GmbH (Germany), and Progetti Srl (Italy).
The animal treatment market is projected to reach ~ USD 50 billion by 2024, at a CAGR of ~6%. Prominent players in this market are Zoetis (US), Merck (US), Boehringer Ingelheim (Germany), Elanco (US), Ceva (France), Phibro Animal Health Corporation (US), Abaxis (US), Virbac SA (France), IDEXX Laboratories, Inc. (US), Neogen Corporation (US), and Heska Corporation (US).
The veterinary care market is projected to reach USD 23 billion in 2025, at a CAGR of 5.7%. The prominent players in the veterinary care market include Zoetis (US), Merck (US), Boehringer Ingelheim (Germany), Elanco (US), Ceva (France), Phibro Animal Health Corporation (US), Virbac SA (France), IDEXX Laboratories, Inc., Neogen Corporation (US), Heska Corporation (US) and others. These players have undertaken several initiatives to capture significant market share.
The sports medicine market is projected to reach USD 7.2 billion by 2025, at a CAGR of 5.7% during the forecast period. The major players operating in the sports medicine market include Arthrex, Inc (US), Smith & Nephew plc (UK), and Stryker Corporation (US). Other players involved in this market include Breg Inc. (US), DJO Global, Inc. (US), Mueller Sports, Inc. (US), Wright Medical Group N.V. (US), Medtronic (Ireland), RTI Surgical (US), Performance Health International Limited (US), KARL STORZ (Germany), and Bauerfeind AG (US), Össur (Iceland), MedShape (US), Cramer Products (US), Biotek ( India).
The global cosmetic dentistry market is projected to reach USD 30.1 billion by 2025, at a CAGR of 6.6%. The prominent players in this market are Henry Schein (US), DENTSPLY Sirona (US), Envista Holdings (US), Align Technology (US), and Straumann Holdings (Switzerland).
The global urinary catheters market size is projected to reach USD 2.6 billion by 2025, at a CAGR of 5.5%. Key players in the Urinary Catheters Market are B. Braun Melsungen AG (Germany), Boston Scientific Corporation (US), Coloplast Ltd. (Denmark), ConvaTec Inc. (UK), Becton, Dickinson and Company (US), and Cardinal Health (US.
The global industrial centrifuge market is projected to reach USD 9.0 billion by 2025, at a CAGR of 4.4% during the forecasting period. Prominent players in the market are ANDRITZ AG (Austria), Alfa Laval Corporate AB (Sweden), GEA Group AG (Germany), Mitsubishi Kakoki Kaisha, Ltd. (Japan), Thomas Broadbent & Sons (UK), FLSmidth & Co. A/S (Denmark), Schlumberger Limited (US), Ferrum AG (Switzerland), Flottweg SE (Germany), SIEBTECHNIK TEMA (Germany), HEINKEL Drying & Separation Group (Germany), Gruppo Pieralisi - MAIP S.p.A. (Italy), SPX Flow Inc. (US), HAUS Centrifuge Technologies (Turkey), Elgin Separation Solutions (US), Comi Polaris Systems, Inc. (US), Dedert Corporation (US), US Centrifuge Systems (US), B&P Littleford (US), and Pneumatic Scale Angelus (US).
The Contrast Media Injectors Market is projected to reach USD 1.9 billion by 2025, at a CAGR of 7.4% during the forecast period. Major players operating in the Contrast Media Injector market include Bayer Ag (Germany), Bracco Imaging S.P.A (Italy), Guerbet Group (France), Ulrich GmbH & Co. KG (Germany), Nemoto Kyorindo Co., Ltd. (Japan), Sino Medical-Device Technology Co., Ltd. (Sinomdt) (China), APOLLO RT Co. Ltd. (Hongkong), Shenzhen Anke High-Tech Co. Ltd. (China), Shenzen Seacrown Electromechanical Co. Ltd. (China), and Medtron AG (Germany).
The Dental Bone Graft Substitute Market is projected to reach USD 659 million by 2025, at a CAGR of 7.9% during the forecast period. Some of the prominent players in the market are Dentsply Sirona (US), Johnson & Johnson (US), Danaher Corporation (US), Medtronic (Ireland), Strauman (US), Zimmer Dental (US) and Geistlich Pharm (Switzerland) are the key players in the global dental bone graft substitute market.
The global breast augmentation market size is projected to reach USD 1,692 million by 2025, at a CAGR of 13.4%. The major players in this market are Johnson & Johnson (US), Allergan (Ireland), Ideal Implant Incorporated (US), Sebbin (France), GC Aesthetics (Ireland), POLYTECH Health & Aesthetics (Germany), Sientra (US), Establishment Labs S.A. (Costa Rica), Silimed (Brazil), Laboratories Arion (France), Guangzhou Wanhe Plastic Materials (China), CEREPLAS (France), HansBiomed (South Korea), and Shanghai Kangning Medical Device Co. (China).
The Patient Lateral Transfer Market is expected to grow from USD 288.7 million in 2020 to USD 446.2 million by 2025, at a CAGR of 9.1% during the forecast period. Some of the prominent players in this market are Stryker Corporation (US), Hill-Rom Holdings, Inc. (US), Sizewise (US), Arjo (Sweden), Haines Medical Australia (Australia), Handicare (Sweden), Medline Industries, Inc. (US), AliMed (US), and Airpal Inc. (US).
The global spirometer market is projected to reach USD 1,285 million by 2025, growing at a CAGR of 11.1%. The rising global incidence of respiratory diseases, increasing aging population, and the technological shift in spirometer devices towards smartphone-based data acquisition are the key factors driving the growth of this market.
The global nurse call systems market is projected to reach $2.7 billion by 2025, at a CAGR of 9.4%. Market growth is driven mainly by factors such as diverse applications of nurse call systems and the availability of technologically advanced nurse call systems. Increasing incidences of Alzheimers disease and the growing number of assisted living centers are expected to provide growth opportunities for players in the market.